NCT03023566View on ClinicalTrials.gov

Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI

CompletedOBSERVATIONAL

Enrollment

250

Participants

Timeline

Start Date

February 9, 2017

Primary Completion Date

November 12, 2017

Study Completion Date

November 12, 2017

Conditions

Brain Diseases

Interventions

DRUG

Dotarem

Dotarem at dose of 0.1 mmol/kg of body weight (routine/standard of care)

Trial Locations (1)

85016

Phoenix Children's Hospital, Phoenix

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Guerbet

INDUSTRY

lead

Phoenix Children's Hospital

OTHER

NCT03023566 - Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI | Biotech Hunter | Biotech Hunter